Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Dosimetric evaluation of MapCHECK 2 and 3DVH in the IMRT delivery quality assurance process.

Song JY, Kim YH, Jeong JU, Yoon MS, Ahn SJ, Chung WK, Nam TK.

Med Dosim. 2014 Summer;39(2):134-8. doi: 10.1016/j.meddos.2013.11.004. Epub 2013 Dec 12.

PMID:
24332483
2.

Statistical analysis of IMRT dosimetry quality assurance measurements for local delivery guideline.

Chung JB, Kim JS, Ha SW, Ye SJ.

Radiat Oncol. 2011 Mar 28;6:27. doi: 10.1186/1748-717X-6-27.

3.
4.

Dependency of planned dose perturbation (PDP) on the spatial resolution of MapCHECK 2 detectors.

Keeling VP, Ahmad S, Algan O, Jin H.

J Appl Clin Med Phys. 2014 Jan 6;15(1):4457. doi: 10.1120/jacmp.v15i1.4457.

PMID:
24423843
5.

Initial experience of ArcCHECK and 3DVH software for RapidArc treatment plan verification.

Infusino E, Mameli A, Conti R, Gaudino D, Stimato G, Bellesi L, D'Angelillo RM, Ramella S, Benassi M, Trodella L.

Med Dosim. 2014 Autumn;39(3):276-81. doi: 10.1016/j.meddos.2014.04.004.

PMID:
25088815
6.

Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.

Mavroidis P, Ferreira BC, Shi C, Lind BK, Papanikolaou N.

Phys Med Biol. 2007 Jul 7;52(13):3817-36. Epub 2007 May 31.

PMID:
17664579
7.

3D DVH-based metric analysis versus per-beam planar analysis in IMRT pretreatment verification.

Carrasco P, Jornet N, Latorre A, Eudaldo T, Ruiz A, Ribas M.

Med Phys. 2012 Aug;39(8):5040-9. doi: 10.1118/1.4736949.

PMID:
22894429
8.

Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.

Stasi M, Bresciani S, Miranti A, Maggio A, Sapino V, Gabriele P.

Med Phys. 2012 Dec;39(12):7626-34. doi: 10.1118/1.4767763.

PMID:
23231310
9.

Modeling the dosimetry of organ-at-risk in head and neck IMRT planning: an intertechnique and interinstitutional study.

Lian J, Yuan L, Ge Y, Chera BS, Yoo DP, Chang S, Yin F, Wu QJ.

Med Phys. 2013 Dec;40(12):121704. doi: 10.1118/1.4828788.

10.

Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.

Cilla S, Deodato F, Digesù C, Macchia G, Picardi V, Ferro M, Sallustio G, De Spirito M, Piermattei A, Morganti AG.

Med Dosim. 2014 Spring;39(1):108-16. doi: 10.1016/j.meddos.2013.11.001. Epub 2013 Dec 15.

PMID:
24342167
11.

Using a novel dose QA tool to quantify the impact of systematic errors otherwise undetected by conventional QA methods: clinical head and neck case studies.

Chan MF, Li J, Schupak K, Burman C.

Technol Cancer Res Treat. 2014 Feb;13(1):57-67. doi: 10.7785/tcrt.2012.500353. Epub 2013 Jun 24.

PMID:
23819494
12.

Comparing measurement-derived (3DVH) and machine log file-derived dose reconstruction methods for VMAT QA in patient geometries.

Tyagi N, Yang K, Yan D.

J Appl Clin Med Phys. 2014 Jul 8;15(4):4645. doi: 10.1120/jacmp.v15i4.4645.

PMID:
25207396
13.

Evaluation of the efficiency and effectiveness of independent dose calculation followed by machine log file analysis against conventional measurement based IMRT QA.

Sun B, Rangaraj D, Boddu S, Goddu M, Yang D, Palaniswaamy G, Yaddanapudi S, Wooten O, Mutic S.

J Appl Clin Med Phys. 2012 Sep 6;13(5):3837. doi: 10.1120/jacmp.v13i5.3837.

PMID:
22955649
14.

Dosimetric effects of multileaf collimator leaf width on intensity-modulated radiotherapy for head and neck cancer.

Hong CS, Ju SG, Kim M, Kim JI, Kim JM, Suh TS, Han Y, Ahn YC, Choi DH, Nam H, Park HC.

Med Phys. 2014 Feb;41(2):021712. doi: 10.1118/1.4860155.

PMID:
24506603
16.

Impact of gantry rotation time on plan quality and dosimetric verification--volumetric modulated arc therapy (VMAT) vs. intensity modulated radiotherapy (IMRT).

Pasler M, Wirtz H, Lutterbach J.

Strahlenther Onkol. 2011 Dec;187(12):812-9. doi: 10.1007/s00066-011-2263-1. Epub 2011 Nov 29.

PMID:
22127360
17.

Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer.

Martinez AA, Yan D, Lockman D, Brabbins D, Kota K, Sharpe M, Jaffray DA, Vicini F, Wong J.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1226-34.

PMID:
11483333
18.

Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer.

Pasler M, Georg D, Wirtz H, Lutterbach J.

Strahlenther Onkol. 2011 Dec;187(12):792-8. doi: 10.1007/s00066-011-1150-0. Epub 2011 Nov 29.

PMID:
22127357
19.

Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans.

Yuan L, Ge Y, Lee WR, Yin FF, Kirkpatrick JP, Wu QJ.

Med Phys. 2012 Nov;39(11):6868-78. doi: 10.1118/1.4757927.

PMID:
23127079
20.

Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.

Abbas AS, Moseley D, Kassam Z, Kim SM, Cho C.

J Appl Clin Med Phys. 2013 May 6;14(3):4269. doi: 10.1120/jacmp.v14i3.4269.

PMID:
23652258
Items per page

Supplemental Content

Write to the Help Desk